Variables, N (%) | HG I/II (N = 349) | HG III (N = 27) | p-value |
---|---|---|---|
Age distribution | 0.757 | ||
≤ 50 | 230 (65.9) | 17 (63.0) | |
> 50 | 119 (34.1) | 10 (37.0) | |
ER expression | 0.005 | ||
Allred score 5–8 | 330 (94.6) | 21 (77.8) | |
Allred score 1–4 | 19 (5.4) | 6 (22.2) | |
PR expression | 0.007 | ||
Allred score 5–8 | 197 (56.4) | 8 (29.6) | |
Allred score 1–4 | 152 (43.6) | 19 (70.4) | |
Ki67 LI * | 0.037 | ||
≥ 14% | 39 (54.9) | 7 (100) | |
< 14% | 32 (45.1) | 0 | |
Clinical T stage | 0.124 | ||
T1 | 39 (11.2) | 1 (3.7) | |
T2 | 177 (50.7) | 19 (70.4) | |
T3 | 133 (38.1) | 7 (25.9) | |
Clinical node positivity | 0.708 | ||
Positive | 26 (7.4) | 1 (3.7) | |
Negative | 323 (92.6) | 26 (96.3) | |
sTIL, mean (range) | 12.9 (5–90) | 38.7 (5–95) | < 0.001# |
sTIL status (cutoff 10%) | < 0.001 | ||
High | 147 (42.1) | 21 (77.8) | |
Low | 202 (57.9) | 6 (22.2) | |
sTIL status (cutoff 20%) | < 0.001 | ||
High | 76 (21.8) | 19 (70.4) | |
Low | 273 (78.2) | 8 (29.6) | |
sTIL status (cutoff 30%) | < 0.001 | ||
High | 45 (12.9) | 15 (55.6) | |
Low | 304 (87.1) | 12 (44.4) |